Surgery Partners (SGRY) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Surgery Partners (SGRY) do?
Surgery Partners Inc (SGRY) is a U.S.-listed company in Healthcare (Medical Care Facilities). What it does: Operates ambulatory surgery centers and surgical hospitals across the United States. Operates short-stay surgical facilities and surgical hospitals through joint-venture partnerships with local physicians. It is worth $3.49B on the market and sold $3.36B over the last year.
- Market cap
- $3.49B
- P/E ratio
- None (reported a loss)
- Annual sales
- $3.36B
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Brief updated
- Nov 18, 2026
SGRY’s flags, in plain English
Each flag is a number from Surgery Partners’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 18, 2026.
Insiders Hold
Insiders own 40.4% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.
Stupid Cash
Can pay this year's bills 2.2 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Still Climbing
Sales up 12.2% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Debt Is Driving
Heavy debt, 199% of shareholder equity. The company owes a lot compared with what it earns. Lenders get paid before shareholders, which leaves management fewer options in a weak year.
1 more green flag and 2 more risk notes open with the free trial. Try it free for 7 days.
Questions about SGRY
How big is Surgery Partners?
Surgery Partners’ market cap is $3.49B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $3.36B: what customers paid the company over the last year, before any costs.
What is SGRY’s P/E ratio?
SGRY has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with SGRY?
The business carries over three billion dollars in long-term debt that requires substantial recurring cash interest payments. That is one risk on Surgery Partners’ card. Its first risk flag is Debt Is Driving, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Surgery Partners’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. SGRY’s filings on SEC.gov. The Margin Monkey is research, not advice.
